ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients Who Discontinued Chemo Before Pembro and in Patients With Immune-Mediated AEs

May 25, 2023

0 Comments
Login to view comments. Click here to Login